Effects of carbamazepine and valproic acid on brain immunoreactive somatostatin and γ-aminobutyric acid in amygdaloid-kindled rats

https://doi.org/10.1016/0014-2999(86)90024-5Get rights and content

Abstract

Somatostatin and γ-aminobutyric acid (GABA) concentrations were evaluated in the brain of kindled rats treated chronically with carbamazepine and valproic acid. Kindled seizures were almost completely blocked by treatment with carbamazepine, whereas the effect of valproic acid was partial, suppressing only generalized seizures. The duration of after-discharge in amygdala was suppressed by carbamazepine not by valproic acid. Carbamazepine induced a decrease in immunoreactive somatostatin concentration and an increase in GABA concentration in the temporal cortex of kindled rats. Valproic acid induced only an increase in GABA concentration. The results suggest that somatostatin may be associated with the suppression of focal seizure in amygdala and GABA may have a role in the suppression of generalized seizures.

References (31)

  • P.S. Albright et al.

    Development of a new pharmacological seizure model: effects of anticonvulsants on cortical- and amygdaloid-kindled seizures in the rat

    Epilepsia

    (1980)
  • G. Assouline et al.

    Cysteamine suppresses kindled seizures in pentylenetetrazol-kindled rats

    European J. Pharmacol.

    (1985)
  • R. Bernasconi et al.

    Effects of antiepileptic drugs on GABA turnover rate (Abstract 251)

    Naunyn-Schmiedeb. Arch. Pharmacol.

    (1979)
  • J. Glowinski et al.

    Regional studies of catecholamines in the rat brain, I

    J. Neurochem.

    (1966)
  • Y. Godin et al.

    Effects of di-n-propylacetate, an anticonvulsive compound, on GABA metabolism

    J. Neurochem.

    (1969)
  • Cited by (34)

    • Antiepileptic drugs as analgesics/adjuvants in inflammatory pain: current preclinical evidence

      2018, Pharmacology and Therapeutics
      Citation Excerpt :

      Receptor binding studies demonstrated that CBZ and OXC's active metabolite does not have binding affinity for GABA receptors (Marangos et al., 1983; Soares-da-Silva et al., 2015). As it was shown that CBZ can increase GABA level in some areas of the brain (Battistin, Varotto, Berlese, & Roman, 1984; Higuchi et al., 1986), it seems possible that antinociceptive/antihyperalgesic effect of CBZ/OXC is partly mediated via GABA release and activation of GABAA receptors in CNS. A non-selective 5-HT receptors antagonist (methysergide), applied systemically in a single dose, didn't influence the antinociception of systemic CBZ in rats with tooth pulp irritated and inflamed by BK (Foong & Satoh, 1984b).

    • Chronic central administration of valproic acid: Increased pro-survival phospho-proteins and growth cone associated proteins with no behavioral pathology

      2012, Pharmacology Biochemistry and Behavior
      Citation Excerpt :

      VPA's ability to help manage seizures is thought to be attributed to its multifaceted capability in affecting several targets. In rats, peripherally administered VPA increased the inhibitory neurotransmitter, γ-aminobutyric acid (GABA) (Godin et al., 1969; Higuchi et al., 1986; Loscher, 1981, 1999), and within the timeframe of increasing GABA, rodents were found to have decreased susceptibility towards seizures (Loscher, 1981; Schechter et al., 1978; Simler et al., 1973). Others report that VPA modulated voltage-gated sodium channels (Cunningham et al., 2003; Vreugdenhil et al., 1998), calcium influx buffering during events of glutamate-induced toxicity (Zhang et al., 2010) and lowered aspartate release (Loscher, 1999).

    View all citing articles on Scopus
    View full text